|
TRIM37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62703184258817E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.4135810257967E-13 |
| Normal-vs-Stage2 |
1.047040E-04 |
| Normal-vs-Stage3 |
1.21458398893992E-13 |
| Normal-vs-Stage4 |
1.63535851527286E-12 |
| Stage1-vs-Stage2 |
8.903900E-02 |
| Stage1-vs-Stage3 |
1.892040E-01 |
| Stage1-vs-Stage4 |
1.860950E-03 |
| Stage2-vs-Stage3 |
1.368360E-02 |
| Stage2-vs-Stage4 |
8.374800E-04 |
| Stage3-vs-Stage4 |
9.655600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
2.27109999999531E-05 |
| Normal-vs-Asian |
5.1749005081092E-10 |
| Caucasian-vs-AfricanAmerican |
3.881200E-01 |
| Caucasian-vs-Asian |
6.813600E-01 |
| AfricanAmerican-vs-Asian |
2.804400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77555756156289E-15 |
| Normal-vs-Female |
2.01594296811436E-12 |
| Male-vs-Female |
6.788400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.21519485982458E-11 |
| Normal-vs-Age(41-60Yrs) |
1.25011112572793E-13 |
| Normal-vs-Age(61-80Yrs) |
7.64344143533435E-12 |
| Normal-vs-Age(81-100Yrs) |
4.592500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.626200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.477800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.257000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.581000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.848600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.176200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.232000E-01 |
| Classical-VS-Follicular |
2.032400E-01 |
| Classical-VS-Other |
1.122040E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
6.517800E-02 |
| Tall-VS-Other |
2.224800E-01 |
| Tall-VS-Normal |
3.50690032568934E-10 |
| Follicular-VS-Other |
2.238200E-02 |
| Follicular-VS-Normal |
1.751999999966E-06 |
| Other-VS-Normal |
3.7838999999984E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83419945898322E-11 |
| Normal-vs-N1 |
8.98636720592094E-12 |
| N0-vs-N1 |
2.349700E-02 |
|
|
